Records containing: Nonalcoholic Fatty Liver
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-09Iron Reduction by Phlebotomy for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-04-21Weight, Energy, Lipids, and the Liver (WELL) Study: Dietary Fat Quality and Ectopic Lipids in the Liver
-
CLINICAL_TRIALS study record update · 2026-04-20A Randomised Controlled Trial Study of the Effect of Fatty Liver Data Analysis and Management Software on the Effectiveness of Intervention in Patients With Non-alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-03-27A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2026-02-03Effect of the Pharmacological Cessation of Menstruation With a GnRH Analog on Hepatic Steatosis in Women With Endometriosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-06The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease: A Pilot Study
-
CLINICAL_TRIALS study record update · 2025-10-23Accurate Point of Care Liver Disease Diagnostics
-
CLINICAL_TRIALS study record update · 2025-10-01Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver Patients
-
CLINICAL_TRIALS study record update · 2025-09-05Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Patients With Type 1 Diabetes Using Vibration-Controlled Transient Elastography and Noninvasive Scores
-
CLINICAL_TRIALS study record update · 2025-07-18Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity-Associated Diseases
-
CLINICAL_TRIALS study record update · 2025-07-18Effect of Anti-osteoporotic Medications on Hepatic Steatosis and Fibrosis of Women With Postmenopausal Osteoporosis and Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2025-06-25A Phase 1a/1b Single Ascending and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OA-235i, a PAR2 Inhibitor, in Adults With Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2025-05-15A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Denifanstat in Patients With Noncirrhotic Metabolic Dysfunction-associated Steatohepatitis (MASH) and F2/F3 Fibrosis (FASCINATE-3)
-
CLINICAL_TRIALS study record update · 2025-05-15A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Denifanstat in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MALSD)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
CLINICAL_TRIALS study record update · 2025-04-02Iron Reduction by Phlebotomy for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2025-02-14Improving the Performance of Ultrasound Shear Wave Elastography (SWE) in Obese Fatty Liver Disease Patients by Developing a Conditionally Increased Output (CIO) Enhanced Ultrasound System
-
CLINICAL_TRIALS study record update · 2024-12-19Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction
-
CLINICAL_TRIALS study record update · 2024-12-04Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
-
CLINICAL_TRIALS study record update · 2024-11-25Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
-
CLINICAL_TRIALS study record update · 2024-05-24Aspirin in Adults With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2024-03-06Understanding the Metabolic Pathology of Pediatric Obesity and NAFLD
-
CLINICAL_TRIALS study record update · 2024-02-20Effect of 12-week Intermittent Calorie Restriction on Liver Fat Content in Comparison With Standard-of-care in Patients With Nonalcoholic Fatty Liver Disease: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-07-11Noninvasive Biomarkers of Metabolic Liver Disease 1.1
-
CLINICAL_TRIALS study record update · 2023-06-18Complex Assessment and Monitoring of Cardio-metabolic Risk in Overweight and Obese Children
-
CLINICAL_TRIALS study record update · 2022-12-27Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease